Home / Why Now
Why now
Why stem cell clinics should build on social media now
Five things are true at the same time in 2026. Together they make this the best time for a stem cell clinic to become the known name in its area.
More patients need help each year
Census Bureau estimates released in June 2026 count 64.6 million Americans aged 65 and over, up 16.2% since 2020. Chronic pain affects 36% of this age group.
In 2019, 20.4% of all U.S. adults had chronic pain. In 2023, the latest year the CDC has published, it was 24.3%. About 33 million adults have osteoarthritis. By 2034, adults aged 65 and over are projected to number 77 million.
U.S. adults with chronic pain
Share of all adults. 2023 is the latest year published.
Not allowed: "Promotion of cell or gene therapies"
Google makes one exception in the United States, for therapies that are FDA licensed or approved and advertised by the license holder. It also allows ads that are only educational or informational.
Google search ads are closed to most clinics
Most businesses find new customers with Google search ads. Stem cell clinics cannot. Google's healthcare policy does not allow ads that promote cell therapies.
This leaves paid social as the main way to reach new patients at scale. Meta allows ads from stem cell clinics, as long as each ad follows its advertising standards.
Your patients are already on Facebook
71% of U.S. adults use Facebook and 84% use YouTube. These are the only two platforms used by a majority of every age group, including adults over 65.
Half of U.S. adults now use Instagram, up from 40% in 2021. Meta lets you show an ad only to adults within driving distance of your clinic, so your budget goes to people who can reach you.
Share of U.S. adults who use each platform
Pew Research Center, latest survey, published November 2025
State laws are opening the door, with advertising rules attached
Three more states passed their own laws on stem cell treatment in 2026, after Utah in 2024 and Florida in 2025. These laws let physicians offer more, and most of them also say what an advertisement must contain.
House Bill 1275
A physician may perform stem cell therapy that is not FDA approved, within their scope of practice, with a signed consent form. Every advertisement must carry a notice that begins "THIS NOTICE MUST BE PROVIDED TO YOU UNDER GEORGIA LAW", in type no smaller than the largest type in the ad.
House Bill 2246
Advertisements for stem cell or regenerative treatments that are not FDA approved must say so, and must encourage the patient to consult their primary care provider. Written consent is required before treatment.
Stem Cell Freedom Act
Physicians may recommend and perform stem cell therapy under set conditions. The state medical board keeps a public register of physicians who offer it.
Senate Bill 1768
Physicians may offer stem cell therapies that are not FDA approved for orthopedics, wound care and pain management, within their scope of practice. Advertising must carry a notice that begins "THIS NOTICE MUST BE PROVIDED TO YOU UNDER FLORIDA LAW" and states that the therapy has not been approved by the FDA.
Senate Bill 199
A provider whose scope of practice includes stem cell therapy may use a therapy the FDA has not approved, provided the patient receives written disclosures.
These are state laws. Federal law still applies, and lawyers who reviewed the Florida law say it conflicts with federal law. A clinic in these states has more room to advertise and more rules to follow. Speak to your own attorney about what applies to your clinic.
Regulators are acting against clinics that advertise badly
In 2026 the FDA sent warning letters to stem cell businesses in Nevada (February 11) and Arizona (August 14). Both letters cite treatment claims made in the companies' marketing, including claims about joint pain and arthritis. The Arizona letter also cites the company's social media accounts.
In January 2025 the FTC announced court orders against the founders of the Stem Cell Institute of America. They were ordered to pay $5,155,146 and are permanently banned from marketing regenerative medicine treatments. The court found that their advertisements made false and misleading claims about how well stem cell injections work and about FDA approval. The FDA states that no regenerative medicine therapy is approved for any orthopedic condition.
What compliant advertising looks likeFTC and State of Georgia, court orders of December 26, 2024
$3,310,146 that may be used for refunds to patients, and $1,845,000 in civil penalties.
The opportunity
The clinic that builds trust first keeps the lead
In 2026 demand is rising, the main search channel is closed, more states are writing advertising rules, and regulators are acting against clinics that make big claims. A clinic that advertises honestly and consistently on Meta now becomes the name local patients know.
Patients see your physicians before they see any other clinic.
Each month of honest, useful ads adds to the number of local people who know your clinic.
We work with one clinic per metro area. When a clinic near you starts, that area is closed.